IPI Legacy Liquidation Co
Equities
IMPL
US45258K1097
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 USD | 0.00% | 0.00% | -87.85% |
Apr. 12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
Apr. 05 | North American Morning Briefing : Investors on -2- | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- IMPL Stock
- News IPI Legacy Liquidation Co
- Transcript : Impel Pharmaceuticals Inc., Q2 2022 Earnings Call, Aug 15, 2022